101 related articles for article (PubMed ID: 3930072)
1. Adherence of tumor cells to endothelial monolayers: inhibition by lymphokines.
Cohen MC; Mecley M; Antonia SJ; Picciano PT
Cell Immunol; 1985 Oct; 95(2):247-57. PubMed ID: 3930072
[TBL] [Abstract][Full Text] [Related]
2. The tumor disappearance reaction: an in vivo effect of a noncytotoxic lymphokine active against tumor cells.
D'Silva H; Munger W; Cohen MC; Cohen S
Clin Immunol Immunopathol; 1985 Mar; 34(3):326-32. PubMed ID: 3918820
[TBL] [Abstract][Full Text] [Related]
3. Lymphokine-induced migration inhibition of murine tumor cells derived from solid neoplasms.
Donskoy M; Forouhar F; Cohen MC
Cancer Res; 1984 Sep; 44(9):3870-2. PubMed ID: 6430556
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of migration of tumor cells in vitro by lymphokine-containing supernatants.
Cohen MC; Goss A; Yoshida T; Cohen S
J Immunol; 1978 Sep; 121(3):840-3. PubMed ID: 99477
[TBL] [Abstract][Full Text] [Related]
5. The role of lymphokines in neoplastic disease.
Cohen MC; Cohen S
Hum Pathol; 1986 Mar; 17(3):264-70. PubMed ID: 2419236
[TBL] [Abstract][Full Text] [Related]
6. Serum migration inhibitory activity against macrophages and tumor cells.
D'Silva H; Cohen M; Yoshida T; Cohen S
Clin Immunol Immunopathol; 1982 Apr; 23(1):77-85. PubMed ID: 6807592
[No Abstract] [Full Text] [Related]
7. [Changes in hepatic regeneration after partial hepatectomy in rats inoculated with Ehrlich ascites carcinoma and with ascites mastocytoma].
Bartoloni Saint Omer F; Tosi P; Colafranceschi M; Bruscagli G
Arch De Vecchi Anat Patol; 1968 Nov; 53(1):165-90. PubMed ID: 4984055
[No Abstract] [Full Text] [Related]
8. Inhibition of basal and tumor necrosis factor-enhanced binding of murine tumor cells to murine endothelium by transforming growth factor-beta 1.
Bereta J; Bereta M; Coffman FD; Cohen S; Cohen MC
J Immunol; 1992 May; 148(9):2932-40. PubMed ID: 1315361
[TBL] [Abstract][Full Text] [Related]
9. Attachment of tumor cells to endothelial monolayers: detection of surface molecules involved in cell-cell binding.
Antonia SJ; Uchida J; Cohen S; Cohen MC
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):281-96. PubMed ID: 2676274
[TBL] [Abstract][Full Text] [Related]
10. Effect of cytokines on tumour cell-endothelial interactions.
Cohen MC; Bereta M; Bereta J
Indian J Biochem Biophys; 1997; 34(1-2):199-204. PubMed ID: 9343951
[TBL] [Abstract][Full Text] [Related]
11. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a tumor-specific T suppressor factor from a T cell hybridoma.
Steele JK; Stammers AT; Levy JG
J Immunol; 1985 Apr; 134(4):2767-78. PubMed ID: 2579156
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumorous ascites.
Cornelius JG; Normann SJ
J Immunol; 1988 Sep; 141(6):2175-80. PubMed ID: 3139755
[TBL] [Abstract][Full Text] [Related]
14. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
Carayanniotis G; Halloran PF
Cell Immunol; 1985 Mar; 91(1):100-10. PubMed ID: 2857596
[TBL] [Abstract][Full Text] [Related]
15. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
16. Migration inhibition of endothelial cells by lymphokine-containing supernatants.
Cohen MC; Picciano PT; Douglas WJ; Yoshida T; Kreutzer DL; Cohen S
Science; 1982 Jan; 215(4530):301-3. PubMed ID: 6797069
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a monoclonal antibody directed to a T cell suppressor factor.
Maier T; Stammers AT; Levy JG
J Immunol; 1983 Oct; 131(4):1843-8. PubMed ID: 6413579
[TBL] [Abstract][Full Text] [Related]
18. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages.
Somers SD; Whisnant CC; Adams DO
J Immunol; 1986 Feb; 136(4):1490-6. PubMed ID: 3080524
[TBL] [Abstract][Full Text] [Related]
19. Effect of inflammatory cytokines on the adherence of tumor cells to endothelium in a murine model.
Bereta M; Bereta J; Cohen S; Zaifert K; Cohen MC
Cell Immunol; 1991 Sep; 136(2):263-77. PubMed ID: 1908352
[TBL] [Abstract][Full Text] [Related]
20. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
Marino PA; Adams DO
J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
